Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

609 Press Releases
DateTitleCompany
24 Jun 11 FDA Complete Response Letter Received for REMOXY Pfizer Inc.,
Published by
Business Wire
24 Jun 11 Pfizer Declares A 20-Cent Third-Quarter 2011 Dividend Pfizer Inc.,
Published by
Business Wire
23 Jun 11 ELIQUIS® (apixaban) Meets Primary and Key Secondary Endpoints in Phase 3 ARISTOTLE Study Bristol-Myers Squibb Company & Pfizer Inc.,
Published by
Business Wire
21 Jun 11 Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury Pfizer Inc.,
Published by
Business Wire
20 Jun 11 GPs PLAY CRUCIAL ROLE IN DUPUYTREN’S DISEASE MANAGEMENT Pfizer Limited,
Published by
Red Consultancy
20 Jun 11 Pfizer and Acura Announce FDA Approval of Oxectatm (Oxycodone HCL, USP) CII Pfizer Inc.,
Published by
Business Wire
14 Jun 11 Innovative Global Science Network - STAR-IDAZ - to Target Animal Diseases Pfizer Animal Health,
Published by
Business Wire
09 Jun 11 Pfizer Recognized By CIO Magazine As One Of The CIO 100 Award Honorees Pfizer Inc.,
Published by
Business Wire
09 Jun 11 Boston’s Top Academic Medical Centers Join Pfizer’s Centers For Therapeutic Innovation Pfizer Inc.,
Published by
Business Wire
08 Jun 11 Pfizer Conducts First “Virtual” Clinical Trial Allowing Patients to Participate Regardless Of Geography Pfizer Inc.,
Published by
Business Wire
07 Jun 11 Pfizer to Announce New Boston-Area Research Partnerships Wednesday, June 8, 2011 2:00 p.m. Pfizer Inc.,
Published by
Business Wire
02 Jun 11 Pfizer and Hisun Sign MOU to Increase Access to Quality and Low-Cost Medicines for Patients in China Pfizer Inc.,
Published by
Business Wire
01 Jun 11 Pfizer Files For European Regulatory Review Of Axitinib For Patients With Advanced Renal Cell Carcinoma Pfizer Inc.,
Published by
Business Wire
31 May 11 Pfizer Invites Public to View and Listen to Webcast of June 6 Pfizer Analyst and Investor Meeting at ASCO Pfizer Inc.,
Published by
Business Wire
25 May 11 Pfizer Announces Detailed Results Of ORAL Sync Showing Investigational Compound Tofacitinib Reduces Signs And Symptoms And Improves Physical Function In Patients With Moderate-To-Severe Active Rheumatoid Arthritis, With Results Seen As Early As Two Weeks Pfizer Inc.,
Published by
Business Wire
22 May 11 Adding Inspra® (eplerenone) To Standard Therapy Reduces The Incidence Of New Onset Atrial Fibrillation/Flutter (AF/F) In Patients With Systolic Heart Failure, Sub-Analysis Shows Pfizer Inc.,
Published by
Business Wire
21 May 11 SUTENT® Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors Pfizer Inc.,
Published by
Business Wire
20 May 11 ELIQUIS® (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement Pfizer Inc.,
Published by
Business Wire
19 May 11 Pfizer Presents New Phase III Data Showing Axitinib Significantly Extended Progression-Free Survival Compared with Sorafenib in Patients with Previously-Treated Advanced Renal Cell Carcinoma Pfizer
19 May 11 Pfizer Presents New Phase 3 Data Showing Axitinib Significantly Extended Progression-Free Survival Compared With Sorafenib In Patients With Previously-Treated Advanced Renal Cell Carcinoma Pfizer Inc.,
Published by
Business Wire
17 May 11 Pfizer Announces Simultaneous Filing Of New Drug Applications For Crizotinib With U.S. Food And Drug Administration And Japanese Ministry Of Health, Labour And Welfare Pfizer Inc.,
Published by
Business Wire
16 May 11 Pfizer To Present New Research From Fifteen Compounds Highlighting Multiple Approaches To Targeting Cancer At 2011 ASCO Annual Meeting Pfizer Inc.,
Published by
Business Wire
11 May 11 Pfizer Animal Health And American Humane Association Partner To Conduct Research On The Power Of The Human-Animal Bond In Pediatric Cancer Patients Pfizer Inc.,
Published by
Business Wire
10 May 11 Alzheimer’s Association Salutes Advocate And Mountaineer Now Climbing Everest As Part Of The 7 Summits Climb For Alzheimer’s Pfizer Inc.,
Published by
Business Wire
09 May 11 Pfizer’s Prevnar 13® Meets All Study Endpoints In Two Pivotal Phase 3 Trials In Adults Aged 50 And Older Presented Today Pfizer Inc.,
Published by
Business Wire
09 May 11 Judges call for 2011 Pfizer Excellence in Oncology Award entries Pfizer Excellence in Oncology Awards
05 May 11 The European Commission Approves Pfizer’s Revatio® (sildenafil) for the Treatment of Pulmonary Arterial Hypertension in Children Pfizer Inc.,
Published by
Business Wire
03 May 11 PRISTIQ® (desvenlafaxine) Extended Release Tablets Shown To Significantly Reduce Number And Severity Of Moderate-To-Severe Hot Flashes Associated With Menopause Pfizer Inc.,
Published by
Business Wire
03 May 11 Pfizer Reports First-Quarter 2011 Results Pfizer Inc.,
Published by
Business Wire
02 May 11 Centrum® multivitamins and Celebrity Personal Trainer Harley Pasternak Share Star-Tested Secrets to Shape up for Summer Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.